Anti-LRIF1 antibodies are used in the immunodetection of the protein ligand dependent nuclear receptor interacting factor 1. In humans, the canonical protein has a reported length of 769 amino acid residues and a mass of 84.6 kDa. Its subcellular localization is in the nucleus and chromosomes. Up to 2 different isoforms have been reported for this protein. It is found to be widely expressed, with the highest expression levels in the heart, liver and placenta. A member of the LRIF1 protein family, LRIF1 is known to be involved with the regulation of transcription. The LRIF1 gene has been associated with the disease, Facioscapulohumeral muscular dystrophy. Synonyms for this target antigen include HP1-binding protein enriched in inactive X chromosome protein 1 and receptor-interacting factor 1. LRIF1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is the most common application for the LRIF1 antibodies listed below. Immunofluorescence and Immunohistochemistry are also common applications.